| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 484 |
| 1 | ETANERCEPT | 412 |
| 2 | METHOTREXATE SODIUM | 384 |
| 3 | INFLIXIMAB | 378 |
| 4 | METHOTREXATE | 356 |
| 5 | TOCILIZUMAB | 355 |
| 6 | ABATACEPT | 350 |
| 7 | SULFASALAZINE | 349 |
| 8 | LEFLUNOMIDE | 348 |
| 9 | CANAKINUMAB | 325 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CANAKINUMAB | 325 | 0.0298 |
| 1 | GOLD | 149 | 0.0257 |
| 2 | ANAKINRA | 323 | 0.0191 |
| 3 | AMMONIA N-13 | 1 | 0.0175 |
| 4 | MINOCYCLINE HYDROCHLORIDE | 87 | 0.0147 |
| 5 | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | 1 | 0.0115 |
| 6 | AMMONIA | 1 | 0.0114 |
| 7 | BENZYL ALCOHOL | 1 | 0.0095 |
| 8 | LEVAMLODIPINE | 1 | 0.0080 |
| 9 | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | 1 | 0.0076 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 444 |
| 1 | Aminosalicylate [EPC] | 358 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 356 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 355 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 350 |
| 5 | Antirheumatic Agent [EPC] | 348 |
| 6 | Interleukin-1 Receptor Antagonist [EPC] | 323 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 318 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 234 |
| 9 | Benzodiazepine [EPC] | 208 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 323 | 0.0191 |
| 1 | Aminosalicylate [EPC] | 358 | 0.0036 |
| 2 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0034 |
| 3 | Antirheumatic Agent [EPC] | 348 | 0.0033 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 355 | 0.0026 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 350 | 0.0025 |
| 6 | Provitamin D2 Compound [EPC] | 61 | 0.0021 |
| 7 | Macrolide Antibacterial [EPC] | 2 | 0.0020 |
| 8 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 2 | 0.0016 |
| 9 | Cholinesterase Inhibitor [EPC] | 30 | 0.0016 |